SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Waiting for the big Kahuna

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: re3 who wrote (46347)3/14/2000 11:24:00 PM
From: sandeep  Read Replies (2) of 94695
 
Anyone who wanted to own biotechs needs to buy them NOW. I did today. Bought IMNX at an average price of 154, but since I don't like taking huge risks, I wrote calls on it when it ran up after I bought it to reduce my buy in price to 143. I believe that is a good price for imnx in the long run. One MUST buy the biotech funds at these prices if one wants to be in the industry at all. Had I bought in earlier, I would have sold on a breach of 10-day EMA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext